- 01Free T4, not TSH, is the line between subclinical and overt
Two people can share the same high TSH and get opposite advice. Normal free T4 keeps it subclinical, and often means watch-and-recheck; low free T4 makes it overt. TSH raises the flag, but free T4 is what draws the line and sets the stage.
- 02Antibodies change the odds, not just the label
Positive TPO antibodies with a raised TSH roughly double the yearly chance of progressing to overt disease, which is why they are worth checking even when free T4 still looks fine.
- 03A high TSH has an explanation, and a stage you can read
A raised TSH is not an open-ended mystery. It has a nameable cause, usually Hashimoto's, and a stage you read off free T4. Most of the uncertainty people feel comes from reading one number alone instead of the whole panel in order.
Hypothyroidism is an underactive thyroid: the gland makes too little thyroid hormone, and on a lab panel it shows up as a high TSH paired with a free T4 that is either still in range (the early, subclinical stage) or frankly low (the overt stage).
Two stages, and the line between them
Hypothyroidism arrives in stages, and the split between them changes how urgently anyone acts. Subclinical hypothyroidism is an elevated TSH with a free T4 still inside the reference range: the pituitary is pushing harder, but the gland is still keeping hormone output in the normal band. Overt hypothyroidism is an elevated TSH with a free T4 that has dropped below range: the gland can no longer keep up despite the extra push. 1
| Stage | TSH | Free T4 | What it means |
|---|---|---|---|
| Subclinical | High | Normal | Gland is straining but still producing enough hormone |
| Overt | High | Low | Gland can no longer keep output in range |
That single distinction, normal free T4 versus low free T4, is why two people with the same high TSH can get very different advice. It is worth reading TSH and free T4 together rather than reacting to one number alone.
How it feels (and why the symptoms fool people)
An underactive thyroid slows the body's metabolism, so the symptoms are real but non-specific: they overlap with sleep debt, low iron, depression, perimenopause, and plain aging. That overlap is why symptoms alone cannot confirm or rule it out, and why the diagnosis lives in the labs.
- Fatigue and heaviness that rest does not fix
- Cold intolerance, dry skin, thinning hair
- Constipation and unexplained weight gain
- Brain fog, low mood, slowed thinking
- Heavier or irregular periods
What usually causes it
In iodine-sufficient countries like the US, the leading cause of an underactive thyroid is Hashimoto's thyroiditis, a chronic autoimmune condition in which the immune system slowly attacks the thyroid gland. 2 The fingerprint of that attack is TPO antibodies (thyroid peroxidase antibodies, immune proteins aimed at an enzyme the thyroid needs to build hormone). They are present in roughly 90% of Hashimoto's cases 6 and mark the process quietly driving the gland toward failure.
The antibodies also change the odds. When TSH is already raised and TPO antibodies are positive, progression to overt hypothyroidism runs about 4% per year, versus about 2% per year when the antibodies are negative. Positive antibodies plus a high TSH roughly double the yearly chance of tipping over. 4
Hypothyroidism is also common enough that a raised TSH is rarely a shock: overt disease affects about 0.3% of the US population and the subclinical form about 4 to 5%, climbing toward 10% in older women. 3
How it shows on a panel
On a panel, TSH moves first. It rises before the free hormones look abnormal, which is why a lab can flag trouble while free T4 still sits in range.
TSH is the pituitary's opinion of your thyroid, not a direct measurement of thyroid hormone; a high TSH usually means the pituitary is shouting at a gland that is falling behind.
So the read is layered: a high TSH raises the flag, free T4 tells you the stage (normal keeps it subclinical, low makes it overt), and TPO antibodies name the cause. Read those in that order and a wall of acronyms becomes a story. The mechanics of why TSH exaggerates small changes live on /biomarkers/tsh. The step-by-step version, as /learn/how-to-read-your-thyroid-panel frames it, comes down to one line: "one number raises the flag, the next tells you the stage, the third names the cause."
What to do with an abnormal result
- 1Confirm before you concludeA single TSH is a snapshot, not a verdict. TSH varies through the day and between assays, so an isolated high value is usually repeated before anyone calls it hypothyroidism.
- 2Add the pieces that decide the stageFree T4 separates subclinical from overt; TPO antibodies point to Hashimoto's. Together they turn one odd number into a picture.
- 3Bring it to a clinicianWhether to treat, watch, or repeat depends on the free T4, the antibodies, your symptoms, your age, and your situation. That judgment is a clinician's, working from your actual numbers.
- 4Recheck on a schedule, not onceA borderline result today can drift. Positive antibodies with a raised TSH especially warrant follow-up, since the odds of progression compound year over year.
When treatment is warranted, the mainstay is levothyroxine, synthetic T4. The body converts that T4 into the active hormone T3 through deiodinase enzymes, so replacing T4 restores the whole supply. 1 Dosing is individual and clinician-set, which is exactly why it is not a number you should reverse-engineer at home.
Mildly raised TSH is the case where the honest answer is often "watch, don't rush." In a randomized trial of older adults with subclinical hypothyroidism, levothyroxine did not deliver the symptom relief people hoped for. 5
Levothyroxine provided no apparent benefits in older persons with subclinical hypothyroidism.Stott et al., TRUST trial, New England Journal of Medicine, 2017
What can help, honestly
The supplement people ask about most is selenium, because of its role in thyroid biology. The evidence is more modest than the marketing.
The thyroid is the most selenium-dense organ in the body, but dense storage is not the same as a supplement that helps: the trial evidence lowers antibody numbers without a clear payoff in how people feel, and past the daily ceiling selenium turns toxic.
More is not safer. The adult tolerable upper limit is 400 mcg of selenium a day, and chronically going past it risks selenosis: brittle hair and nails, stomach upset, and nerve symptoms. 7 A typical US diet already supplies plenty, so supplementing on top mostly pushes you toward that ceiling for a benefit the trials never clearly showed. For the full picture, including what the trials did and did not find, read /compounds/selenium. It is not a substitute for the workup above.
The one thing to hold onto
Read together, the panel tells a short story: a high TSH raises the flag, free T4 sets the stage (normal keeps it subclinical, low makes it overt), and TPO antibodies usually point to the autoimmune Hashimoto's cause behind it. That is something a clinician can name and manage. Most of the uncertainty people feel comes from reading one number in isolation. Read the whole panel in order and one scary number becomes a manageable finding.
Do not self-treat with thyroid hormone. Levothyroxine dosing is a clinician's decision guided by repeat labs, and overtreatment strains the heart and bones. Whether a raised TSH is subclinical or overt, and whether to treat or watch, is a clinician's call from your actual free T4, antibodies, age, and symptoms. Pregnancy and existing heart disease change the calculus and need specialist care; if you are pregnant or trying to conceive, thyroid targets are different and time-sensitive. Selenium is not a treatment: stay under the adult upper limit of 400 mcg a day, since chronic excess causes selenosis.
Citations
- Jonklaas J, et al. Guidelines for the Treatment of Hypothyroidism. American Thyroid Association Task Force. Thyroid. 2014;24(12):1670-1751.
- Chaker L, Bianco AC, Jonklaas J, Peeters RP. Hypothyroidism. Lancet. 2017;390(10101):1550-1562.
- Hollowell JG, et al. Serum TSH, T4, and thyroid antibodies in the United States population (NHANES III). J Clin Endocrinol Metab. 2002;87(2):489-499.
- Vanderpump MPJ, et al. The incidence of thyroid disorders in the community: the Whickham Survey twenty-year follow-up. Clin Endocrinol (Oxf). 1995;43(1):55-68.
- Stott DJ, et al. Thyroid Hormone Therapy for Older Adults with Subclinical Hypothyroidism (TRUST trial). N Engl J Med. 2017;376(26):2534-2544.
- Garber JR, et al. Clinical Practice Guidelines for Hypothyroidism in Adults (AACE/ATA). Thyroid. 2012;22(12):1200-1235.
- National Institutes of Health, Office of Dietary Supplements. Selenium: Fact Sheet for Health Professionals. Tolerable upper intake level 400 mcg/day for adults; chronic excess causes selenosis.
Educational context only, not medical advice or a diagnosis. Always discuss your results with a clinician.